247 related articles for article (PubMed ID: 18651672)
21. Biomarker discovery in psychiatric disorders.
Schwarz E; Bahn S
Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
[TBL] [Abstract][Full Text] [Related]
22. Proteomic toolbox for autoimmunity research.
Wu T; Mohan C
Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
[TBL] [Abstract][Full Text] [Related]
23. Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry.
Hu L; Boos KS; Ye M; Wu R; Zou H
J Chromatogr A; 2009 Jul; 1216(28):5377-84. PubMed ID: 19482289
[TBL] [Abstract][Full Text] [Related]
24. Differential gel-based proteomic approach for cancer biomarker discovery using human plasma.
Na K; Lee MJ; Jeong HJ; Kim H; Paik YK
Methods Mol Biol; 2012; 854():223-37. PubMed ID: 22311764
[TBL] [Abstract][Full Text] [Related]
25. Biomarker discovery using molecular profiling approaches.
Walker SJ; Xu A
Int Rev Neurobiol; 2004; 61():1-30. PubMed ID: 15482809
[No Abstract] [Full Text] [Related]
26. A robust method for proteomic characterization of mouse cartilage using solubility-based sequential fractionation and two-dimensional gel electrophoresis.
Wilson R; Bateman JF
Matrix Biol; 2008 Oct; 27(8):709-12. PubMed ID: 18762257
[TBL] [Abstract][Full Text] [Related]
27. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery.
Isserlin R; Emili A
Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
Pernemalm M; Orre LM; Lengqvist J; Wikström P; Lewensohn R; Lehtiö J
J Proteome Res; 2008 Jul; 7(7):2712-22. PubMed ID: 18549256
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in mass spectrometry-based peptidome analysis.
Hu L; Ye M; Zou H
Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
[TBL] [Abstract][Full Text] [Related]
30. Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS.
Sinclair J; Timms JF
Methods; 2011 Aug; 54(4):361-9. PubMed ID: 21397697
[TBL] [Abstract][Full Text] [Related]
31. Solid-phase hexapeptide ligand libraries open up new perspectives in the discovery of biomarkers in human plasma.
Léger T; Lavigne D; Le Caër JP; Guerrier L; Boschetti E; Fareh J; Feldman L; Laprévote O; Meilhac O
Clin Chim Acta; 2011 Apr; 412(9-10):740-7. PubMed ID: 21219894
[TBL] [Abstract][Full Text] [Related]
32. Affinity prefractionation for MS-based plasma proteomics.
Pernemalm M; Lewensohn R; Lehtiö J
Proteomics; 2009 Mar; 9(6):1420-7. PubMed ID: 19235168
[TBL] [Abstract][Full Text] [Related]
33. Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery.
Issaq HJ; Blonder J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1222-8. PubMed ID: 19117811
[TBL] [Abstract][Full Text] [Related]
34. Relationship between sample loading amount and peptide identification and its effects on quantitative proteomics.
Liu K; Zhang J; Wang J; Zhao L; Peng X; Jia W; Ying W; Zhu Y; Xie H; He F; Qian X
Anal Chem; 2009 Feb; 81(4):1307-14. PubMed ID: 19146458
[TBL] [Abstract][Full Text] [Related]
35. Peptidomics: identification of pathogenic and marker peptides.
Xiang Y; Kurokawa MS; Kanke M; Takakuwa Y; Kato T
Methods Mol Biol; 2010; 615():259-71. PubMed ID: 20013215
[TBL] [Abstract][Full Text] [Related]
36. Quantitative peptide and protein profiling by mass spectrometry.
Schmidt A; Bisle B; Kislinger T
Methods Mol Biol; 2009; 492():21-38. PubMed ID: 19241025
[TBL] [Abstract][Full Text] [Related]
37. Protein identification and Peptide expression resolver: harmonizing protein identification with protein expression data.
Kearney P; Butler H; Eng K; Hugo P
J Proteome Res; 2008 Jan; 7(1):234-44. PubMed ID: 18062667
[TBL] [Abstract][Full Text] [Related]
38. Reference map for liquid chromatography-mass spectrometry-based quantitative proteomics.
Kim YJ; Feild B; Fitzhugh W; Heidbrink JL; Duff JW; Heil J; Ruben SM; He T
Anal Biochem; 2009 Oct; 393(2):155-62. PubMed ID: 19538932
[TBL] [Abstract][Full Text] [Related]
39. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
40. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
